National Campaign for Childhood Cancer
This course was a scientific gathering of Experts with various backgrounds who are engaged in investigations relevant to RRMM.
This webinar was a scientific educational activity discussing the last updated and key points on Bone Health in Multiple Myeloma.
This journal club was a scientific educational activity on identification of Lenalidomide refractory Multiple Myeloma patients using the IMWG criteria and Discuss CANDOR & MMY1001 trials.
This journal club was a scientific-educational activity on Latest Readout in RRMM & Sub-analysis in Len exposed and Len refractory.
This journal club was a scientific-educational activity discussing the last updated and key points on Management of Acute Lymphoblastic Leukemia.
This journal club was a scientific-educational activity discussing data from BLAST trial, reflecting on the role of achieving and sustaining Minimal Residual Disease negativity status. The Role of Blinatumomab in managing Minimal Residual Disease (MRD) in B-Cell Acute Lymphoblastic Leukemia (B-ALL). One of its key goals was to share clinical experience on the use of […]
This journal club was a scientific-educational activity discussing on the convenient treatment protocols for the management of relapsed/ refractory Multiple Myeloma patients and sharing data of Carfilzomib from Moreau et al. 2018 A.R.R.O.W. Trial.
Speaker: Dr. Joseph Mikhael Affiliations: Chief Medical Officer, International Myeloma Foundation. Professor, Translational Genomics Research Institute (TGen), City of Hope Cancer Center, Arizona, United States This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020.
Speaker: Dr. Carolina Moreno Affiliations: Associate Progessor of Medicine, Autonomous Univeristy of Barcelona, Senior Consultant, Department of Hematology, Hospital de Saint Paul Santa Creu, Spain. This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020.
